Close Menu

Tecan

Following Illumina's acquisition of digital microfluidics firm Advanced Liquid Logic last month, the company is now planning how it will integrate ALL's electrowetting technology into new sequencing sample preparation products and evaluating what other applications to pursue that

Affymetrix has been awarded US Patent No. 8,492,121, "Complexity management of genomic DNA."
Shoulian Dong is named as the inventor.

Sony of Tokyo has received US Patent No.

Asuragen of Austin, Texas, has received US Patent No. 8,465,914, "Method and compositions involving microRNA." Methods are claimed for isolating, enriching, and labeling miRNA molecules, and for preparing and using arrays or other detection techniques for miRNA analysis.

Canon has been awarded US Patent No. 8,466,272, "Probe set and method for identifying HLA allele."
Mamoru Tsukada has been named as inventor on the patent.

NEW YORK (GenomeWeb News) – Illumina today said that it has launched a partnership program aimed at developing automation methods for its TruSeq and Nextera Sample Preparation kits.

Swift Biosciences has launched Accel-NGS DNA Library Kit, a PCR-free library prep kit that requires 5 nanograms of input DNA.

Austrian tools vendor Tecan announced this week that Arizona State University researchers have acquired one of its hybridization systems and two of its scanners for the purpose of processing protein microarrays.

Eppendorf recently launched the Mastercycler Nexus X1, the latest addition to the company's Mastercycler range of PCR instruments.

Akonni Biosystems has been awarded US Patent No. 8,334,117, "Temperature control device with a flexible temperature control surface."

Pages

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.